|
The ABL Advisor Deal Tables
SELECTED TRANSACTION DETAILS
JPMorgan Chase, Others Provide $700MM Facility to Haemonetics
|
Lenders/Participants
|
JPMorgan Chase Bank [Co-Lead Arranger, Joint Bookrunner]
Citibank [Co-Lead Arranger, Joint Bookrunner]
Citizens Bank [Co-Lead Arranger, Joint Bookrunner]
|
|
Structure
|
Revolving & Term Credit Facilities
|
|
Amount
|
$700.000
Million
|
|
Borrower(s)
|
Haemonetics Corporation
|
|
Description
|
A new $700 million credit agreement with its lenders, comprised of a $350 million senior unsecured term loan A and a $350 million senior unsecured revolving credit facility, both due 2023. The Company has used initial proceeds from the new credit agreement to repay its $254 million senior unsecured term loan A due June 2019. Borrowings under the new credit facilities initially bear interest at an annual rate of LIBOR plus 1.25%, which may change based on the Company's leverage ratio. The revolving credit facility carries an unused fee of 0.175% annually, which may change based on the Company's leverage ratio.
|
|
Industry
|
Medical
|
| Related Tags |
Citibank, Citizens Bank, JPMorgan Chase Bank
|
ABL Advisor
Deal Tables
2024
|
|
|
|